3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals
Pharmaceutics · 17.01.2023 · 15 (2) · 313
DOI: 10.3390/pharmaceutics15020313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 17.01.2023. Verfasst von Dolores R Serrano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Food Science, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain. Die Arbeit wurde bisher 194-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Complutense University of Madrid, European Society of Clinical Microbiology and Infectious Diseases, Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
3D printing technologies enable medicine customization adapted to patients’ needs. There are several 3D printing techniques available, but majority of dosage forms and medical devices are printed using nozzle-based extrusion, laser-writing systems, and powder binder jetting. 3D printing has been demonstrated for a broad range of applications in development and targeting solid, semi-solid, and locally applied or implanted medicines. 3D-printed solid dosage forms allow the combination of one or more drugs within the same solid dosage form to improve patient compliance, facilitate deglutition, tailor the release profile, or fabricate new medicines for which no dosage form is available. Sustained-release 3D-printed implants, stents, and medical devices have been used mainly for joint replacement therapies, medical prostheses, and cardiovascular applications. Locally applied medicines, such as wound dressing, microneedles, and medicated contact lenses, have also been manufactured using 3D printing techniques. The challenge is to select the 3D printing technique most suitable for each application and the type of pharmaceutical ink that should be developed that possesses the required physicochemical and biological performance. The integration of biopharmaceuticals and nanotechnology-based drugs along with 3D printing (“nanoprinting”) brings printed personalized nanomedicines within the most innovative perspectives for the coming years. Continuous manufacturing through the use of 3D-printed microfluidic chips facilitates their translation into clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics and Food Science, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.
- Instituto Universitario de Farmacia Industrial, Universidad Complutense de Madrid, 28040 Madrid, Spain.
- Department of Physical Chemistry, Complutense University of Madrid, 28040 Madrid, Spain.
- Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
- CRUK Formulation Unit, School of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
ORCID-Profile: Dolores R Serrano, Aytug Kara, Brayan J Anaya, Bianca I Ramirez, Sergio A Sánchez-Guirales, Helga K Ruiz, Aikaterini Lalatsa
Förderung
- Complutense University of Madrid
- European Society of Clinical Microbiology and Infectious Diseases
- Spanish Ministry of Science and Innovation
- Universidad Complutense de Madrid
- Ministry of Science and Innovation
Zitieren
APA
Serrano, D. R., Kara, A., Yuste, I., Luciano, F. C., Ongoren, B., Anaya, B. J., Molina, G., Diez, L., Ramirez, B. I., Ramirez, I. O., Sánchez-Guirales, S. A., Fernández-García, R., Bautista, L., Ruiz, H. K., & Lalatsa, A. (2023). 3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics, 15(2), 313. https://doi.org/10.3390/pharmaceutics15020313
Vancouver
Serrano DR, Kara A, Yuste I, Luciano FC, Ongoren B, Anaya BJ, et al. 3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics. 2023;15(2):313. doi:10.3390/pharmaceutics15020313
BibTeX
@article{Serrano2023,
author = {Serrano, Dolores R and Kara, Aytug and Yuste, Iván and Luciano, Francis C and Ongoren, Baris and Anaya, Brayan J and Molina, Gracia and Diez, Laura and Ramirez, Bianca I and Ramirez, Irving O and Sánchez-Guirales, Sergio A and Fernández-García, Raquel and Bautista, Liliana and Ruiz, Helga K and Lalatsa, Aikaterini},
title = {3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {2},
pages = {313},
doi = {10.3390/pharmaceutics15020313}
}
EUVIMED